Published in J Virol on October 01, 2001
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 23.81
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell (1996) 17.81
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell (1989) 9.66
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science (1990) 8.07
Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (1997) 6.23
HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr (1989) 6.16
Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science (1985) 6.02
The genetic data environment an expandable GUI for multiple sequence analysis. Comput Appl Biosci (1994) 5.68
Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J Virol (1992) 5.31
Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes. J Virol (1991) 5.03
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (1986) 4.35
Significance of premature stop codons in env of simian immunodeficiency virus. J Virol (1989) 3.60
Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. Nature (1990) 3.54
Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol (1991) 3.46
Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol (1997) 3.33
Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol (1992) 3.16
Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med (1999) 3.11
SIV adaptation to human cells. Nature (1989) 3.09
Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell (1995) 3.03
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol (1992) 2.86
Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J Virol (1991) 2.84
Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (1987) 2.61
The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J Virol (1989) 2.46
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol (1997) 2.46
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34
A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients. J Infect Dis (1993) 2.28
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J Virol (1993) 2.26
Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine. Lancet (1991) 2.10
Animal models of AIDS. FASEB J (1989) 1.82
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci U S A (1995) 1.69
Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res Hum Retroviruses (1990) 1.56
Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Exp Cell Res (1990) 1.53
Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J Virol (1997) 1.49
Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant. J Virol (1993) 1.49
Use of simian immunodeficiency viruses for AIDS research. Intervirology (1989) 1.44
Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol (1995) 1.39
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc Natl Acad Sci U S A (1992) 1.35
Pathologic features of SIV-induced disease and the association of macrophage infection with disease evolution. AIDS Res Hum Retroviruses (1992) 1.34
Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol (1994) 1.22
The natural history of cryptosporidial diarrhoea in HIV-infected patients. AIDS (1993) 1.17
Distribution of SIV in lymph nodes of serially sacrificed rhesus monkeys. AIDS Res Hum Retroviruses (1995) 1.15
SIV infection of macaques as a model for AIDS pathogenesis. Int Rev Immunol (1992) 1.11
SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque. J Med Primatol (1997) 1.07
Monoclonal antibodies directed against human immunodeficiency virus (HIV) gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and simian immunodeficiency virus. J Gen Virol (1988) 1.01
Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques. J Gen Virol (1999) 0.97
Dynamics of macrophage and T cell infection by HIV. J Theor Biol (1999) 0.97
Molecular changes associated with replication of simian immunodeficiency virus in human cells. J Med Primatol (1990) 0.96
Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression. Semin Immunol (1998) 0.93
SIVsmm infection of macaque and mangabey monkeys: correlation between in vivo and in vitro properties of different isolates. Dev Biol Stand (1990) 0.93
Viral genetic determinants in SIVsmmPBj pathogenesis. J Med Primatol (1994) 0.91
A strategy for cloning infectious molecular clones of retroviruses from serum or plasma. J Virol Methods (2000) 0.90
Use of simian immunodeficiency virus for vaccine research. J Med Primatol (1990) 0.87
The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques. J Gen Virol (2000) 0.85
Role of chemokine receptors in HIV-1 infection and pathogenesis. Adv Virus Res (1999) 0.85
Primate models for AIDS vaccine development. AIDS (1996) 0.84
Simian immunodeficiency virus DNA vaccine trial in macaques. Ann N Y Acad Sci (1995) 0.83
Immunohistochemical localization of type D retrovirus serotype 1 in the digestive tract of rhesus monkeys with simian AIDS. J Med Primatol (1990) 0.80
Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies. AIDS (1989) 0.79
Direct amplification and cloning of up to 5-kb lentivirus genomes from serum. Biotechniques (1996) 0.76
Functional association of cyclophilin A with HIV-1 virions. Nature (1994) 6.82
Hospitalization costs associated with homelessness in New York City. N Engl J Med (1998) 5.90
Hospital characteristics and mortality rates. N Engl J Med (1989) 4.97
Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev (1994) 4.95
Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol (2004) 4.12
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Cloned pigs produced by nuclear transfer from adult somatic cells. Nature (2000) 3.51
Precise epitope mapping of the murine transformation-associated protein, p53. EMBO J (1985) 2.98
Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet (1996) 2.77
Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses (1993) 2.29
Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53. Nucleic Acids Res (1984) 2.28
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother (1994) 2.26
Indoor moulds and asthma. J R Soc Health (1988) 2.19
Sources and incidence of airborne Aspergillus fumigatus (Fres). Clin Allergy (1976) 2.17
Asthma admissions and thunderstorms: a study of pollen, fungal spores, rainfall, and ozone. QJM (2001) 2.10
B-cell subpopulations identified by two-colour fluorescence analysis. Nature (1982) 2.06
Protozoa as sources of antigen in 'humidifier fever'. Nature (1976) 2.06
Evaluation of the HCFA model for the analysis of mortality following hospitalization. Health Serv Res (1992) 1.99
Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis (1993) 1.95
Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol Reprod (2003) 1.91
A comparison of noncontrast computerized tomography with excretory urography in the assessment of acute flank pain. J Urol (1999) 1.85
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol (1998) 1.79
Incomplete particles of adenovirus. II. Kinetics of formation and polypeptide composition of adenovirus type 2. Virology (1974) 1.74
Characteristics of fatal ambulance crashes in the United States: an 11-year retrospective analysis. Prehosp Emerg Care (2001) 1.64
The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol (1991) 1.63
K88ab gene of Escherichia coli encodes a fimbria-like protein distinct from the K88ab fimbrial adhesin. J Bacteriol (1984) 1.62
Fungal spores in lung and sputum. Clin Allergy (1978) 1.55
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob Agents Chemother (1996) 1.51
HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest (1998) 1.49
Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat Med (1997) 1.48
Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses (2008) 1.46
Insertion mutations in the control region of the Gal operon of E. coli. I. Biological characterization of the mutations. Mol Gen Genet (1972) 1.44
Prestige of training programs and experience of bypass surgeons as factors in adjusted patient mortality rates. Med Care (1999) 1.41
The relationship between adjusted hospital mortality and the results of peer review. Health Serv Res (1993) 1.40
Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci U S A (1990) 1.39
Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol (1997) 1.38
Tryptic fingerprint analysis of adenovirus types 2, 5 and 12 DNA-Binding proteins. Virology (1976) 1.35
Adenovirus-infected, cell-specific, DNA-binding proteins. Cold Spring Harb Symp Quant Biol (1975) 1.34
Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest (1996) 1.32
HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine (1994) 1.31
Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J Virol (1998) 1.30
Regional variations in grass pollen seasons in the UK, long-term trends and forecast models. Clin Exp Allergy (1999) 1.28
Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J Gen Virol (1996) 1.27
Early processes of echovirus 12-infection: elution, penetration, and uncoating under the influence of rhodanine. Virology (1979) 1.24
Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen. J Virol (1988) 1.24
Cytological demonstration of mitotic crossing-over in man. Cytogenet Cell Genet (1976) 1.23
Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol (1986) 1.23
Protecting HIV databases. Nature (1995) 1.22
Relationships between airborne fungal spore concentration of Cladosporium and the summer climate at two sites in Britain. Int J Biometeorol (2003) 1.20
The relationship between group C adenovirus tumor antigen and the adenovirus single-strand DNA-binding protein. Cell (1976) 1.19
Isolation and characterization of adenovirus type 12 DNA binding proteins. Virology (1975) 1.18
Evolution of a simian immunodeficiency virus pathogen. J Virol (1998) 1.15
Purification and partial characterization of poliovirus protease 2A by means of a functional assay. J Virol (1988) 1.13
Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment. Virology (2001) 1.12
CD70 represents the human ligand for CD27. Int Immunol (1994) 1.12
AIDS vaccine developments. Nature (1992) 1.11
The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol (1993) 1.10
Expression and release of CD27 in human B-cell malignancies. Blood (1993) 1.10
Localization by Q-banding of mitotic chiasmata in cases of Bloom's syndrome. Chromosoma (1976) 1.09
Comparing hospitals that perform coronary artery bypass surgery: the effect of outcome measures and data sources. Am J Public Health (1994) 1.09
Psychosocial outcomes for preschool children and families after surgery for complex congenital heart disease. Pediatr Cardiol (2007) 1.08
Phenotype and function of human B cells expressing CD70 (CD27 ligand). Eur J Immunol (1996) 1.08
The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27. Endocrinology (1992) 1.08
Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees. J Immunol (1999) 1.07
Assessing providers of coronary revascularization: a method for peer review organizations. Am J Public Health (1992) 1.07
Mortality after coronary angioplasty and coronary artery bypass surgery (the national Medicare experience). Am J Cardiol (1992) 1.06
Cytogenetics of Bloom's syndrome. Cancer Genet Cytogenet (1986) 1.06
A recombinant HIV-1 virus-like particle vaccine: from concepts to a field study. Antibiot Chemother (1971) (1996) 1.05
Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes. Eur J Immunol (1991) 1.04
Charges for childhood asthma by hospital characteristics. Pediatrics (1998) 1.04
Long terminal repeat U3 length polymorphism of human foamy virus. Virology (1997) 1.04
Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model. Kidney Int (1992) 1.03
Triple check for antigen specificity of B cells during germinal centre reactions. Immunol Today (1997) 1.03
Dicentric chromosomes and the inactivation of the centromere. Hum Genet (1986) 1.02
Mouse model to study the replication of primate foamy viruses. J Gen Virol (1997) 1.00
Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Hum Retroviruses (1994) 1.00
Seroprevalence of specific viral infections in confiscated orangutans (Pongo pygmaeus). J Med Primatol (1998) 1.00
2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity. J Med Chem (1987) 0.99
Gene trap integrations expressed in the developing heart: insertion site affects splicing of the PT1-ATG vector. Dev Dyn (1998) 0.99
Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med (1994) 0.98
B-cell subpopulations identifiable by two-color fluorescence analysis using a dual-laser FACS. Ann N Y Acad Sci (1982) 0.98
Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques. J Gen Virol (1999) 0.97
Mitotic modifications and aberrations in cancer. Crit Rev Oncog (1989) 0.97
The major polypeptides of the murine-mammary-tumor virus isolated by plant-lectin affinity chromatography. Eur J Biochem (1977) 0.97
Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology (1997) 0.96